Delivery Order SPE2DB22D9316-SPE2DB24FYN82
Award Date 4/8/24
Potential Completion Date 4/29/24
Potential Value $4.3K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth up to $25,529.76 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 4563969889 - Perjeta 420 mg/14 ml vial, 14 ml, with a performance period through April 1, 2024. This delivery order is issued under DMS Pharmaceutical Group's indefinite delivery contract SPE2DB24FSW68 with DLA, which has a ceiling value of up to...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $54,687.24 to DMS Pharmaceutical Group Inc. on September 16, 2025, for the supply of Perjeta 420 mg/14 ml vials. This delivery order is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. The ultimate completion date for this delivery is October 7, 2025, and performance will...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of various pharmaceutical products. The $23,579.40 contract covers the delivery of Perjeta (pertuzumab) 420 mg/14 mL vials to support the recurring medical supply needs of military health facilities. This award is part of DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery contract with the DLA under the SPE2DB...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of Perjeta (pertuzumab) 420 mg/14 ml vial. The order has a potential value of $24,831.00 and a completion date of January 18, 2024. This delivery order is likely part of a larger indefinite delivery contract that DMS Pharmaceutical Group Inc. holds with the Defense Logistics Agency to provide a variety of pharmaceutical and...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $17,019.84, is for the provision of Perjeta 420 mg/14 ml vials to support the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA, valued at up to...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc. on September 22, 2025, for the supply of Perjeta 420 mg/14 mL vials totaling $27,343.62 with firm fixed pricing. This delivery order was issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA valued at $499,999,999 and effective through November 2026. The award carries no set-aside designation and requires completion by October 14, 2025, with performance based in Park Ridge,...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $82,770.00 contract is for the supply of 4,560,409,012 units of Perjeta 420 mg/14 ml vial. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) under the SPE2DB program, which allows the DLA to issue fixed-price orders for a comprehensive range of...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at $28,969.50 by the Defense Logistics Agency to provide 14 vials of Perjeta 420 mg/14 ml. The delivery order was issued against DMS Pharmaceutical Group's existing indefinite delivery contract with the Defense Logistics Agency to supply pharmaceuticals and medical supplies with a total potential value of up to $5 million through December 2025. As a woman-owned small business, DMS Pharmaceutical Group will...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide a 14 milliliter vial of the drug Perjeta (pertuzumab) 420 milligram. The order, valued at $12,764.88, has a completion date of February 12, 2024. DMS Pharmaceutical Group holds multiple contracts and indefinite delivery vehicles with DLA Troop Support Medical to supply various pharmaceutical and medical products to military treatment facilities...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $12,764.88 contract is for the supply of Perjeta 420 mg/14 ml vial, with a period of performance through June 25, 2024. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This...